{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:20:57Z","timestamp":1792696857485,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000858","name":"University of Sheffield","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11657-019-0564-7","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T21:03:11Z","timestamp":1549314191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability"],"prefix":"10.1007","volume":"14","author":[{"given":"E. V.","family":"McCloskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/jbmr.2301","volume":"29","author":"JA Kanis","year":"2014","unstructured":"Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926\u20131928","journal-title":"J Bone Miner Res"},{"key":"564_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.2016.11032","volume":"316","author":"AR Cappola","year":"2016","unstructured":"Cappola AR, Shoback DM (2016) Osteoporosis therapy in postmenopausal women with high risk of fracture. JAMA 316:715\u2013716","journal-title":"JAMA"},{"key":"564_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2016) Binding selectivity of abaloparatide for pth-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149","journal-title":"Endocrinology"},{"key":"564_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2014-3718","volume":"100","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, O'Dea LS, Zanchetta JR, Kumar P, Banks K, McKay K, Lyttle CR, Hattersley G (2015) Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 100:697\u2013706","journal-title":"J Clin Endocrinol Metab"},{"key":"564_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CAF, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, for the ACTIVE Study Investigators (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316:722\u2013733","journal-title":"JAMA"},{"key":"564_CR6","unstructured":"International Osteoporosis Foundation (2018) Fracture risk assessment. \nhttps:\/\/www.iofbonehealth.org\/osteoporosis-musculoskeletal-disorders\/osteoporosis\/diagnosis\/fracture-risk-assessment\n\n Accessed 8 June 2018"},{"key":"564_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198713340.003.0004","volume-title":"Osteoporosis risk assessment","author":"CCC Holroyd","year":"2014","unstructured":"Holroyd CCC, Dennison E (2014) Osteoporosis risk assessment. Oxford University Press, UK"},{"key":"564_CR8","unstructured":"Committee for Medicinal Products for Human Use (2006) Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. 1\u201310"},{"key":"564_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) Frax and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"564_CR10","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s00198-015-3173-3","volume":"26","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Kanis JA, Oden A, Burge RT, Mitlak BH, Johansson H, McCloskey EV (2015) FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporos Int 26:2677\u20132684","journal-title":"Osteoporos Int"},{"key":"564_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/jbmr.1606","volume":"27","author":"EV McCloskey","year":"2012","unstructured":"McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A, Lewiecki EM, Lorenc R, Libanati C, Kanis JA (2012) Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with frax. J Bone Miner Res 27:1480\u20131486","journal-title":"J Bone Miner Res"},{"key":"564_CR12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/jbmr.3163","volume":"32","author":"EV McCloskey","year":"2017","unstructured":"McCloskey EV, Johansson H, Oden A, Harvey NC, Jiang H, Modin S, Fitzpatrick L, Kanis JA (2017) The effect of abaloparatide-sc on fracture risk is independent of baseline frax fracture probability: a post hoc analysis of the ACTIVE study. J Bone Miner Res 32:1625\u20131631","journal-title":"J Bone Miner Res"},{"key":"564_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-008-0786-9","volume":"20","author":"EV McCloskey","year":"2009","unstructured":"McCloskey EV, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K, Jalava T, Kanis JA (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy\u2014additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20:811\u2013817","journal-title":"Osteoporos Int"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Crabtree N, Duffy H, Parle J, Rashid F, Stant K, Taylor K, Thomas C, Knox E, Tenneson C, Williams H, Adams D, Bion V, Blacklock J, Dyer T, Bratherton S, Fidler M, Knight K, McGurk C, Smith K, Young S, Collins K, Cushnaghan J, Arundel C, Bell K, Clark L, Collins S, Gardner S, Mitchell N (2018) Screening in the community to reduce fractures in older women (scoop): a randomised controlled trial. Lancet 391:741\u2013747","journal-title":"Lancet"},{"key":"564_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1214\/aoms\/1177731601","volume":"13","author":"A Wald","year":"1942","unstructured":"Wald A (1942) Asymptotically shortest confidence intervals. Ann Math Stat 13:127\u2013137","journal-title":"Ann Math Stat"},{"key":"564_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jbmr.2991","volume":"32","author":"F Cosman","year":"2017","unstructured":"Cosman F, Hattersley G, Hu MY, Williams GC, Fitzpatrick LA, Black DM (2017) Effects of abaloparatide-SC on fractures and bone mineral density in subgroups of postmenopausal women with osteoporosis and varying baseline risk factors. J Bone Miner Res 32:17\u201323","journal-title":"J Bone Miner Res"},{"key":"564_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jbmr.3042","volume":"32","author":"TJ Martin","year":"2017","unstructured":"Martin TJ, Seeman E (2017) Abaloparatide is an anabolic, but does it spare resorption? J Bone Miner Res 32:11\u201316","journal-title":"J Bone Miner Res"},{"key":"564_CR18","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mellstr\u00f6m D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J, Sawicki AZ, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0564-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-019-0564-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0564-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:12:40Z","timestamp":1580843560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-019-0564-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s11657-019-0564-7","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. McCloskey reports that he and\/or his institution has received consultancy fees, and\/or research funding, and\/or honoraria from AgNovos, Alliance for Better Bone Health, Amgen, Consilient, Fresenius Kabi,\u00a0GE Lunar, GSK, Hologic, Internis, Lilly, Merck, Novartis, ONO, Pfizer, Radius Health, Inc., Redx Oncology, Roche, Servier, UCB, and Wyeth. Dr. Kanis reports grants from Amgen and Lilly, nonfinancial support from Medimaps and other support from AgNovos. Dr. Kanis is the architect of FRAX but has no financial interest in it. Drs. Fitzpatrick, Williams, and Hu are employees of and hold stock in Radius Health, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"15"}}